Braveheart Bio, Inc. (BRVE)
17.21
-0.20
(-1.18%)
USD |
NASDAQ |
Nov 06, 10:07
Braveheart Bio Debt to Equity Ratio : 0.0049 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0049 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0093 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Bristol Myers Squibb Co. | 1.915 |
| Trulieve Cannabis Corp. | 0.7522 |
| Journey Medical Corp. | 0.7953 |
| Turn Therapeutics, Inc. | 8.911 |
| ANI Pharmaceuticals, Inc. | 1.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 126.96M |
| Total Liabilities (Quarterly) | 9.342M |
| Shareholders Equity (Quarterly) | 117.61M |
| Current Ratio | 13.63 |